Esophageal Adenocarcinoma — Trials

Esophageal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 70
Recruiting: 45
Ph III recruiting: 4
Growth YoY: —
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07277413	A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors	recruiting	Phase 1	260	IDEAYA BiosciencesINDUSTRY	1	Sep 28, 2026	clinicaltrials
NCT06005493	Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors	recruiting	Phase 1 / Phase 2	392	AstraZenecaINDUSTRY	8	Sep 25, 2026	clinicaltrials
NCT06324357